$SGHT News

Sight Sciences (NASDAQ:SGHT) Screens Strong on Minervini Trend Template and High-Growth Momentum

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

Why Is Sight Sciences Stock Gaining Thursday?

HC Wainwright & Co. Initiates Coverage On Sight Sciences with Buy Rating, Announces Price Target of $14

Sight Sciences: Signs Of Progress, But Plenty Of Work Remains

Sight Sciences (SGHT) Stock Gets Fair Value Boost After Analyst Target Increases

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Sight Sciences, Inc. (SGHT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease

Sight Sciences Announces Updated FDA Indications For TearCare, Effective August 18

Sight Sciences (SGHT) Q2 2026 Earnings Call Transcript

UBS Maintains Buy on Sight Sciences, Raises Price Target to $8

Sight Sciences, Inc. (SGHT) Q2 2026 Earnings Call Transcript

Sight Sciences Inc (SGHT) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and Raised ...

Sight Sciences Q2 Earnings Call Highlights

Sight Sciences (SGHT) Stock Sees Modest Fair Value Cut As Analysts Revisit Guidance

Sight Sciences (NASDAQ:SGHT) Beats Q2 Estimates and Raises Guidance, but Shares Dip

Sight Sciences (SGHT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Sight Sciences Reports Second Quarter 2026 Financial Results